Medical devices
The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.
The deal comes about a week after GE announced new details about its plans to spin off its healthcare unit.
David Rosen, a partner and public policy lawyer at Foley & Lardner, discusses the agency's recently wrapped Software Precertification Pilot Program and what it means for the future of digital health regulation.
The UK-based wearable medical device company plans to use the funds to expand in Europe and North America.
Kaleidoscope, Surge, Optellum, Cionic and Arcascope also announce funding rounds.
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
Device Connect for Fitbit aims to help healthcare and life science organizations use and analyze data from Fitbit's health-tracking wearables.
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
The company will use the funding to support the commercial expansion of its product.
The company said the clearance will allow more pharma companies to use Tasso+ for decentralized clinical trials.